Individual Stock News 1. Kuaishou (01024.HK) announced on the Hong Kong Stock Exchange its plan to issue US dollar and RMB senior notes. The net proceeds from the note issuance will be primarily used for general corporate purposes. 2. RoboSense (02

2026-01-14

Individual Stock News 1. Kuaishou (01024.HK) announced on the Hong Kong Stock Exchange its plan to issue US dollar and RMB senior notes. The net proceeds from the note issuance will be primarily used for general corporate purposes. 2. RoboSense (02498.HK): Sales of LiDAR products in 2025 are expected to reach approximately 912,000 units. 3. Kanglong Chemical (03759.HK): Adjusted net profit attributable to shareholders in 2025 is expected to increase by 10%-15% year-on-year. 4. Q Technology (01478.HK) issued a profit warning: Annual consolidated profit is expected to increase by approximately 400% to 450% year-on-year. 5. China Coal Energy (01898.HK): Sales of marketable coal in 2025 are expected to be approximately 256 million tons, a decrease of 10.2% year-on-year. 6. Xiaocaiyuan (00999.HK): Plans to establish a joint venture to develop online malls and "community ready-to-eat food stores" and other businesses. 7. Jianye Real Estate (00832.HK): Total contracted property sales in 2025 are expected to reach RMB 8.467 billion, a decrease of 16.3% year-on-year. 8. Hopson Development Holdings (00754.HK): Total contracted sales in 2025 are expected to reach approximately RMB 15.607 billion, a decrease of 6.15% year-on-year. 9. GDS Holdings-SW (09698.HK): Recovered approximately 95% of the principal invested in DayOne, with a return on investment of nearly 6.5 times. 10. Henlius Biotech (02696.HK): The Biologics License Application (BLA) for Hanbetai (bevacizumab injection) has been accepted by the U.S. Food and Drug Administration (FDA). 11. Changjetong (01588.HK) issued a profit warning: It expects profit attributable to owners of the parent company in 2025 to be between RMB 76 million and RMB 85 million, representing a year-on-year increase of 127% to 154%. 12. Shenwan Hongyuan (06806.HK): Shenwan Hongyuan Securities has received approval from the China Securities Regulatory Commission (CSRC) to publicly issue corporate bonds with a total face value not exceeding RMB 60 billion to professional investors. 13. Anhui Wantong Expressway (00995.HK): A consortium has been selected as the successful bidder for the concession project of the Shucheng-Tongcheng section of the S19 Huainan-Tongcheng Expressway. The winning bid price is RMB 7.237 billion. 14. Xinming Life Science (00474.HK) responds to high shareholding concentration: No less than 25% of the company's issued shares are held by the public, and the company can comply with the public float requirements under the Stock Exchange Listing Rules.